Rystiggo Patient Assistance Program

 

Introduction

Living with generalized myasthenia gravis can involve ongoing treatment and careful management of symptoms. For adults who are AChR- or MuSK-antibody positive, Rystiggo offers a targeted treatment approach designed to reduce the IgG autoantibodies that contribute to the condition.

Rystiggo is administered once weekly for six weeks as part of a treatment cycle, with subsequent cycles based on clinical evaluation. For eligible patients who face challenges accessing their medication, Prescription Hope may provide assistance with navigating the prescription assistance process.

What Is the Rystiggo Patient Assistance Program?

Pharmaceutical manufacturers understand that some of their brand-name products may be too expensive for average Americans to afford. Unfortunately, prices are increasing, and more patients are looking for alternative ways to save.

Those looking to save on their Rystiggo may benefit from the Rystiggo patient assistance program. Manufacturers offer qualified patients access to programs to provide more affordable medication.

However, many of these programs are difficult to apply for. They often include complex processes, time-consuming forms and phone calls, and necessary document collection.

Thankfully, Prescription Hope provides a solution.

How Expert Advocates Help Make Rystiggo More Affordable

Prescription Hope’s expert Rystiggo patient advocates provide personalized prescription assistance to help qualified patients navigate the steps needed to access affordable medication. Through dedicated Rystiggo medication support, our medication access advocates help manage applications, required documentation, provider coordination, and program follow-ups, offering dependable myasthenia gravis patient support throughout the process.

Patient-Focused Medication Support

For 20 years, patients have turned to Prescription Hope for a simpler, more affordable, and less stressful way to access brand-name medications. Our patient advocates deliver personalized prescription assistance and dependable medication support, guiding qualified patients through each step while providing compassionate myasthenia gravis patient support.

Simplified Access to Specialty Therapies

Prescription Hope helps qualified patients overcome cost barriers through specialty medication assistance. Our team provides access support and biologic medication assistance, guiding patients as they explore specialty therapy access options that may ease financial strain and make treatment more manageable.

Ongoing Prescription Assistance

Prescription Hope provides prescription support to help qualified patients maintain access to the medication they need. Through our patient assistance services, the team offers ongoing medication assistance with paperwork, program updates, questions, renewals, and refill scheduling. This personalized prescription access support delivers dependable myasthenia gravis prescription assistance, helping patients feel informed and supported throughout the process.

Rystiggo Patient Assistance Eligibility

Rystiggo patient assistance eligibility may be based on program-specific income guidelines, insurance status, a valid prescription, and legal U.S. residency. Because assistance requirements can vary, patients seeking generalized myasthenia gravis assistance can enroll with Prescription Hope for a personalized review of their prescription assistance eligibility.

Simple Enrollment With Expert Support

Prescription Hope simplifies Rystiggo assistance enrollment and medication assistance enrollment with application support for each patient assistance application and prescription assistance application.

An advocate responds within 1–2 business days, then gathers documents, coordinates signatures, submits the application, and follows up. Approved patients typically receive medication within two weeks, though shipping times vary.

Understanding Rystiggo

How Rystiggo Works

Rystiggo is a neonatal Fc receptor (FcRn) blocker that binds to FcRn and reduces circulating IgG levels. This also reduces levels of pathogenic AChR and MuSK autoantibodies that contribute to generalized myasthenia gravis.

What Conditions Does Rystiggo Treat?

This medication is indicated for the treatment of generalized myasthenia gravis in adult patients who are positive for anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies.

The medication should not be described as a treatment for all forms of myasthenia gravis. Safety and effectiveness in pediatric patients have not been established.

Benefits of Treatment

It can help reduce the effects of pathogenic IgG autoantibodies associated with AChR- or MuSK-positive generalized myasthenia gravis. In the pivotal clinical study, Rystiggo produced statistically significant improvements in MG-ADL and QMG scores compared with placebo. Treatment is administered once weekly for six weeks per treatment cycle, with subsequent cycles based on clinical evaluation.

Important Safety Information and Side Effects

Infections

Rystiggo may increase the risk of infection. Treatment should be delayed in patients with an active infection until the infection has resolved. Patients should be monitored for signs and symptoms of infection, and treatment may need to be withheld if a serious infection occurs.

Aseptic Meningitis

Serious cases of aseptic meningitis have been reported with Rystiggo. Patients should be evaluated if symptoms consistent with meningitis develop.

Hypersensitivity Reactions

Hypersensitivity reactions, including angioedema and rash, have occurred. Patients should be monitored during treatment and for 15 minutes after administration is complete.

Vaccination Considerations

Live-attenuated or live vaccines are not recommended during treatment because this medication reduces IgG levels. Age-appropriate vaccinations should be evaluated before beginning a new treatment cycle.

Drug Interactions

Rystiggo can reduce the systemic exposure and effectiveness of medications that bind to the human neonatal Fc receptor (FcRn). These include some immunoglobulin products, monoclonal antibodies, and antibody-derived products containing an IgG Fc domain.

Long-term concomitant use should be carefully evaluated. When long-term use of an FcRn-binding medication is essential, the prescribing information recommends considering discontinuation of Rystiggo and use of alternative therapies.

Pregnancy and Breastfeeding

Human pregnancy data for Rystiggo are limited. Animal studies in pregnant monkeys showed increased embryonic death, reduced offspring body weight, and impaired immune function. A pregnancy exposure registry is available.

There are no data on the presence of this medication in human milk or its effects on a breastfed infant or milk production. The potential benefits of breastfeeding should be considered alongside the mother’s clinical need for treatment and the potential effects on the breastfed child.

Common Side Effects

The most common adverse reactions include headache, infections, diarrhea, fever, hypersensitivity reactions, and nausea. Other reported reactions include administration-site reactions, abdominal pain, and joint pain.

Access to Multiple Medications

Managing several prescriptions can feel complicated. Prescription Hope helps qualified patients streamline specialty medication access and navigate a prescription assistance program for multiple brand-name and specialty treatments.

For a simple $70.00 per month, per medication, our team provides personalized coordination and medication affordability support to make prescription costs and access easier to manage.

Why Choose Prescription Hope for Rystiggo Assistance?

Patient-Focused Medication Support

For 20 years, patients have relied on Prescription Hope for simpler, more affordable access to brand-name medications. Through Prescription Hope assistance, our team provides personalized medication assistance, dependable prescription support, and compassionate patient support to guide qualified patients through every step.

Simplified Access to Specialty Therapies

When treatment costs feel overwhelming, Prescription Hope is here to help qualified patients explore specialty medication assistance with care and understanding. Through compassionate access support, our team provides biologic medication access and specialty therapy assistance to ease financial stress and make the path to treatment feel more manageable.

Ongoing Prescription Assistance

Prescription Hope offers Rystiggo prescription assistance to help qualified patients stay connected to the medication they need. Through patient assistance, our team provides ongoing medication support with paperwork, program updates, questions, renewals, and refill scheduling. This personalized prescription access support includes medication affordability assistance, helping patients feel informed and cared for throughout the process.